In vivo evaluation of drug dialyzability in a rat model of hemodialysis

It is important to calculate the drug removal by hemodialysis (HD) for drug dosing regimens in HD patients. However, there are limited and inconsistent information about the dialyzability of drugs by HD. Therefore, the aim of our study is to evaluate drug removal by utilizing a rat model of HD (HD r...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:PloS one 2020-06, Vol.15 (6), p.e0233925-e0233925
Hauptverfasser: Fukunaga, Masaki, Kadowaki, Daisuke, Mori, Mika, Hagiwara, Satomi, Narita, Yuki, Saruwatari, Junji, Tanaka, Ryota, Watanabe, Hiroshi, Yamasaki, Keishi, Taguchi, Kazuaki, Ito, Hiroki, Maruyama, Toru, Otagiri, Masaki, Hirata, Sumio
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page e0233925
container_issue 6
container_start_page e0233925
container_title PloS one
container_volume 15
creator Fukunaga, Masaki
Kadowaki, Daisuke
Mori, Mika
Hagiwara, Satomi
Narita, Yuki
Saruwatari, Junji
Tanaka, Ryota
Watanabe, Hiroshi
Yamasaki, Keishi
Taguchi, Kazuaki
Ito, Hiroki
Maruyama, Toru
Otagiri, Masaki
Hirata, Sumio
description It is important to calculate the drug removal by hemodialysis (HD) for drug dosing regimens in HD patients. However, there are limited and inconsistent information about the dialyzability of drugs by HD. Therefore, the aim of our study is to evaluate drug removal by utilizing a rat model of HD (HD rat) and to extrapolate this result to the drug removal rate in HD patients. HD rats received bilateral nephrectomy and HD for 2 h. The dialysis removal of 6 drugs was evaluated in HD rats. Dialysis efficiency, plasma protein binding rate (PBR) and distribution volume (Vd) of drugs were also measured. Furthermore, we examined the correlation between the dialyzability of drug in HD rats and humans and constructed the prediction formula of the drug dialyzability in HD patients. The clearance of urea and creatinine and normalized dialysis dose in HD rats were 0.83 ± 0.07 mL/min, 0.70 ± 0.08 mL/min, and 0.13 ± 0.06, respectively. The drug dialyzability in HD rats was similar to reported clinical data except for doripenem. A higher correlation was observed between drug dialyzability in reported clinical data and HD rats which were adjusted for PBR (r.sup.2 = 0.936; p < 0.001) compared to unadjusted (r.sup.2 = 0.812; p = 0.009). Therefore, we constructed the prediction formula of the drug dialyzability in HD patients by utilizing the HD rat model and PBR. This study is useful for evaluating the dialyzability of high-risk drugs in a clinical setting and might provide appropriate preclinical dialyzability data for new drug.
doi_str_mv 10.1371/journal.pone.0233925
format Article
fullrecord <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_2412532996</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A626469863</galeid><doaj_id>oai_doaj_org_article_0411000611ae4ea4a8b5c0f1f817187d</doaj_id><sourcerecordid>A626469863</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5845-e3263e1e85e994df73c5a2273e3e6d5fba5754ae9b7d3c21be613e7aa19abb0d3</originalsourceid><addsrcrecordid>eNqNkt-L1DAQx4so3nn6HwgWBNGHXfOjSZsX4Tj0XDg48NdrmLbTbpa0WZN2cf3rTd0qV7kHyUOGyWe-kxm-SfKckjXlOX27c6Pvwa73rsc1YZwrJh4k51RxtpKM8Id34rPkSQg7QgQvpHycnHEmOFGCnSfXmz49mINL8QB2hMG4PnVNWvuxTWsD9vgTSmPNcExNn0LqYUg7V6OdoC3GcGKCCU-TRw3YgM_m-yL5-uH9l6uPq5vb683V5c2qEkUmVsiZ5EixEKhUVjc5rwQwlnPkKGvRlCBykQGqMq95xWiJknLMAaiCsiQ1v0henHT31gU97yBoltE4ElNKRmJzImoHO733pgN_1A6M_p1wvtXgB1NZ1CSjlBAiKQXMEDIoSlGRhjYFzWmRT93ezd3GssO6wn7wYBeiy5febHXrDjpninEhosDrWcC77yOGQXcmVGgt9OjG079VUeSsiOjLf9D7p5upFuIApm9c7FtNovpSMplJVUgeqfU9VDw1dqaKhmlMzC8K3iwKIjPgj6GFMQS9-fzp_9nbb0v21R12i2CHbXB2nHwWlmB2AivvQvDY_F0yJXry-59t6MnvevY7_wVl5-_Y</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2412532996</pqid></control><display><type>article</type><title>In vivo evaluation of drug dialyzability in a rat model of hemodialysis</title><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><source>Public Library of Science (PLoS)</source><creator>Fukunaga, Masaki ; Kadowaki, Daisuke ; Mori, Mika ; Hagiwara, Satomi ; Narita, Yuki ; Saruwatari, Junji ; Tanaka, Ryota ; Watanabe, Hiroshi ; Yamasaki, Keishi ; Taguchi, Kazuaki ; Ito, Hiroki ; Maruyama, Toru ; Otagiri, Masaki ; Hirata, Sumio</creator><contributor>Shimosawa, Tatsuo</contributor><creatorcontrib>Fukunaga, Masaki ; Kadowaki, Daisuke ; Mori, Mika ; Hagiwara, Satomi ; Narita, Yuki ; Saruwatari, Junji ; Tanaka, Ryota ; Watanabe, Hiroshi ; Yamasaki, Keishi ; Taguchi, Kazuaki ; Ito, Hiroki ; Maruyama, Toru ; Otagiri, Masaki ; Hirata, Sumio ; Shimosawa, Tatsuo</creatorcontrib><description>It is important to calculate the drug removal by hemodialysis (HD) for drug dosing regimens in HD patients. However, there are limited and inconsistent information about the dialyzability of drugs by HD. Therefore, the aim of our study is to evaluate drug removal by utilizing a rat model of HD (HD rat) and to extrapolate this result to the drug removal rate in HD patients. HD rats received bilateral nephrectomy and HD for 2 h. The dialysis removal of 6 drugs was evaluated in HD rats. Dialysis efficiency, plasma protein binding rate (PBR) and distribution volume (Vd) of drugs were also measured. Furthermore, we examined the correlation between the dialyzability of drug in HD rats and humans and constructed the prediction formula of the drug dialyzability in HD patients. The clearance of urea and creatinine and normalized dialysis dose in HD rats were 0.83 ± 0.07 mL/min, 0.70 ± 0.08 mL/min, and 0.13 ± 0.06, respectively. The drug dialyzability in HD rats was similar to reported clinical data except for doripenem. A higher correlation was observed between drug dialyzability in reported clinical data and HD rats which were adjusted for PBR (r.sup.2 = 0.936; p &lt; 0.001) compared to unadjusted (r.sup.2 = 0.812; p = 0.009). Therefore, we constructed the prediction formula of the drug dialyzability in HD patients by utilizing the HD rat model and PBR. This study is useful for evaluating the dialyzability of high-risk drugs in a clinical setting and might provide appropriate preclinical dialyzability data for new drug.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0233925</identifier><identifier>PMID: 32530952</identifier><language>eng</language><publisher>San Francisco: Public Library of Science</publisher><subject>Analysis ; Animals ; Biology and Life Sciences ; Catheters ; Correlation ; Correlation analysis ; Creatinine ; Dialysate ; Dialysis ; Dialyzers ; Dosage ; Drug development ; Drug dosages ; Drug interactions ; Drug therapy ; Drugs ; Engineering and Technology ; Evaluation ; Hemodialysis ; Hemodialysis patients ; Laboratories ; Medicine and Health Sciences ; Nephrectomy ; Pharmaceutical sciences ; Pharmacy ; Physical Sciences ; Physiology ; R&amp;D ; Research &amp; development ; Research and Analysis Methods ; Sodium ; Urea ; Veins &amp; arteries</subject><ispartof>PloS one, 2020-06, Vol.15 (6), p.e0233925-e0233925</ispartof><rights>COPYRIGHT 2020 Public Library of Science</rights><rights>2020 Fukunaga et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2020 Fukunaga et al 2020 Fukunaga et al</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5845-e3263e1e85e994df73c5a2273e3e6d5fba5754ae9b7d3c21be613e7aa19abb0d3</citedby><cites>FETCH-LOGICAL-c5845-e3263e1e85e994df73c5a2273e3e6d5fba5754ae9b7d3c21be613e7aa19abb0d3</cites><orcidid>0000-0003-3821-5966 ; 0000-0003-1584-249X ; 0000-0002-3064-1963</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292355/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292355/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,2096,2915,23845,27901,27902,53766,53768,79343,79344</link.rule.ids></links><search><contributor>Shimosawa, Tatsuo</contributor><creatorcontrib>Fukunaga, Masaki</creatorcontrib><creatorcontrib>Kadowaki, Daisuke</creatorcontrib><creatorcontrib>Mori, Mika</creatorcontrib><creatorcontrib>Hagiwara, Satomi</creatorcontrib><creatorcontrib>Narita, Yuki</creatorcontrib><creatorcontrib>Saruwatari, Junji</creatorcontrib><creatorcontrib>Tanaka, Ryota</creatorcontrib><creatorcontrib>Watanabe, Hiroshi</creatorcontrib><creatorcontrib>Yamasaki, Keishi</creatorcontrib><creatorcontrib>Taguchi, Kazuaki</creatorcontrib><creatorcontrib>Ito, Hiroki</creatorcontrib><creatorcontrib>Maruyama, Toru</creatorcontrib><creatorcontrib>Otagiri, Masaki</creatorcontrib><creatorcontrib>Hirata, Sumio</creatorcontrib><title>In vivo evaluation of drug dialyzability in a rat model of hemodialysis</title><title>PloS one</title><description>It is important to calculate the drug removal by hemodialysis (HD) for drug dosing regimens in HD patients. However, there are limited and inconsistent information about the dialyzability of drugs by HD. Therefore, the aim of our study is to evaluate drug removal by utilizing a rat model of HD (HD rat) and to extrapolate this result to the drug removal rate in HD patients. HD rats received bilateral nephrectomy and HD for 2 h. The dialysis removal of 6 drugs was evaluated in HD rats. Dialysis efficiency, plasma protein binding rate (PBR) and distribution volume (Vd) of drugs were also measured. Furthermore, we examined the correlation between the dialyzability of drug in HD rats and humans and constructed the prediction formula of the drug dialyzability in HD patients. The clearance of urea and creatinine and normalized dialysis dose in HD rats were 0.83 ± 0.07 mL/min, 0.70 ± 0.08 mL/min, and 0.13 ± 0.06, respectively. The drug dialyzability in HD rats was similar to reported clinical data except for doripenem. A higher correlation was observed between drug dialyzability in reported clinical data and HD rats which were adjusted for PBR (r.sup.2 = 0.936; p &lt; 0.001) compared to unadjusted (r.sup.2 = 0.812; p = 0.009). Therefore, we constructed the prediction formula of the drug dialyzability in HD patients by utilizing the HD rat model and PBR. This study is useful for evaluating the dialyzability of high-risk drugs in a clinical setting and might provide appropriate preclinical dialyzability data for new drug.</description><subject>Analysis</subject><subject>Animals</subject><subject>Biology and Life Sciences</subject><subject>Catheters</subject><subject>Correlation</subject><subject>Correlation analysis</subject><subject>Creatinine</subject><subject>Dialysate</subject><subject>Dialysis</subject><subject>Dialyzers</subject><subject>Dosage</subject><subject>Drug development</subject><subject>Drug dosages</subject><subject>Drug interactions</subject><subject>Drug therapy</subject><subject>Drugs</subject><subject>Engineering and Technology</subject><subject>Evaluation</subject><subject>Hemodialysis</subject><subject>Hemodialysis patients</subject><subject>Laboratories</subject><subject>Medicine and Health Sciences</subject><subject>Nephrectomy</subject><subject>Pharmaceutical sciences</subject><subject>Pharmacy</subject><subject>Physical Sciences</subject><subject>Physiology</subject><subject>R&amp;D</subject><subject>Research &amp; development</subject><subject>Research and Analysis Methods</subject><subject>Sodium</subject><subject>Urea</subject><subject>Veins &amp; arteries</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><sourceid>DOA</sourceid><recordid>eNqNkt-L1DAQx4so3nn6HwgWBNGHXfOjSZsX4Tj0XDg48NdrmLbTbpa0WZN2cf3rTd0qV7kHyUOGyWe-kxm-SfKckjXlOX27c6Pvwa73rsc1YZwrJh4k51RxtpKM8Id34rPkSQg7QgQvpHycnHEmOFGCnSfXmz49mINL8QB2hMG4PnVNWvuxTWsD9vgTSmPNcExNn0LqYUg7V6OdoC3GcGKCCU-TRw3YgM_m-yL5-uH9l6uPq5vb683V5c2qEkUmVsiZ5EixEKhUVjc5rwQwlnPkKGvRlCBykQGqMq95xWiJknLMAaiCsiQ1v0henHT31gU97yBoltE4ElNKRmJzImoHO733pgN_1A6M_p1wvtXgB1NZ1CSjlBAiKQXMEDIoSlGRhjYFzWmRT93ezd3GssO6wn7wYBeiy5febHXrDjpninEhosDrWcC77yOGQXcmVGgt9OjG079VUeSsiOjLf9D7p5upFuIApm9c7FtNovpSMplJVUgeqfU9VDw1dqaKhmlMzC8K3iwKIjPgj6GFMQS9-fzp_9nbb0v21R12i2CHbXB2nHwWlmB2AivvQvDY_F0yJXry-59t6MnvevY7_wVl5-_Y</recordid><startdate>20200612</startdate><enddate>20200612</enddate><creator>Fukunaga, Masaki</creator><creator>Kadowaki, Daisuke</creator><creator>Mori, Mika</creator><creator>Hagiwara, Satomi</creator><creator>Narita, Yuki</creator><creator>Saruwatari, Junji</creator><creator>Tanaka, Ryota</creator><creator>Watanabe, Hiroshi</creator><creator>Yamasaki, Keishi</creator><creator>Taguchi, Kazuaki</creator><creator>Ito, Hiroki</creator><creator>Maruyama, Toru</creator><creator>Otagiri, Masaki</creator><creator>Hirata, Sumio</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0003-3821-5966</orcidid><orcidid>https://orcid.org/0000-0003-1584-249X</orcidid><orcidid>https://orcid.org/0000-0002-3064-1963</orcidid></search><sort><creationdate>20200612</creationdate><title>In vivo evaluation of drug dialyzability in a rat model of hemodialysis</title><author>Fukunaga, Masaki ; Kadowaki, Daisuke ; Mori, Mika ; Hagiwara, Satomi ; Narita, Yuki ; Saruwatari, Junji ; Tanaka, Ryota ; Watanabe, Hiroshi ; Yamasaki, Keishi ; Taguchi, Kazuaki ; Ito, Hiroki ; Maruyama, Toru ; Otagiri, Masaki ; Hirata, Sumio</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5845-e3263e1e85e994df73c5a2273e3e6d5fba5754ae9b7d3c21be613e7aa19abb0d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Analysis</topic><topic>Animals</topic><topic>Biology and Life Sciences</topic><topic>Catheters</topic><topic>Correlation</topic><topic>Correlation analysis</topic><topic>Creatinine</topic><topic>Dialysate</topic><topic>Dialysis</topic><topic>Dialyzers</topic><topic>Dosage</topic><topic>Drug development</topic><topic>Drug dosages</topic><topic>Drug interactions</topic><topic>Drug therapy</topic><topic>Drugs</topic><topic>Engineering and Technology</topic><topic>Evaluation</topic><topic>Hemodialysis</topic><topic>Hemodialysis patients</topic><topic>Laboratories</topic><topic>Medicine and Health Sciences</topic><topic>Nephrectomy</topic><topic>Pharmaceutical sciences</topic><topic>Pharmacy</topic><topic>Physical Sciences</topic><topic>Physiology</topic><topic>R&amp;D</topic><topic>Research &amp; development</topic><topic>Research and Analysis Methods</topic><topic>Sodium</topic><topic>Urea</topic><topic>Veins &amp; arteries</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fukunaga, Masaki</creatorcontrib><creatorcontrib>Kadowaki, Daisuke</creatorcontrib><creatorcontrib>Mori, Mika</creatorcontrib><creatorcontrib>Hagiwara, Satomi</creatorcontrib><creatorcontrib>Narita, Yuki</creatorcontrib><creatorcontrib>Saruwatari, Junji</creatorcontrib><creatorcontrib>Tanaka, Ryota</creatorcontrib><creatorcontrib>Watanabe, Hiroshi</creatorcontrib><creatorcontrib>Yamasaki, Keishi</creatorcontrib><creatorcontrib>Taguchi, Kazuaki</creatorcontrib><creatorcontrib>Ito, Hiroki</creatorcontrib><creatorcontrib>Maruyama, Toru</creatorcontrib><creatorcontrib>Otagiri, Masaki</creatorcontrib><creatorcontrib>Hirata, Sumio</creatorcontrib><collection>CrossRef</collection><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological &amp; Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science &amp; Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies &amp; Aerospace Collection</collection><collection>Agricultural &amp; Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Meteorological &amp; Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agricultural Science Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Advanced Technologies &amp; Aerospace Database</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials Science Collection</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fukunaga, Masaki</au><au>Kadowaki, Daisuke</au><au>Mori, Mika</au><au>Hagiwara, Satomi</au><au>Narita, Yuki</au><au>Saruwatari, Junji</au><au>Tanaka, Ryota</au><au>Watanabe, Hiroshi</au><au>Yamasaki, Keishi</au><au>Taguchi, Kazuaki</au><au>Ito, Hiroki</au><au>Maruyama, Toru</au><au>Otagiri, Masaki</au><au>Hirata, Sumio</au><au>Shimosawa, Tatsuo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>In vivo evaluation of drug dialyzability in a rat model of hemodialysis</atitle><jtitle>PloS one</jtitle><date>2020-06-12</date><risdate>2020</risdate><volume>15</volume><issue>6</issue><spage>e0233925</spage><epage>e0233925</epage><pages>e0233925-e0233925</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>It is important to calculate the drug removal by hemodialysis (HD) for drug dosing regimens in HD patients. However, there are limited and inconsistent information about the dialyzability of drugs by HD. Therefore, the aim of our study is to evaluate drug removal by utilizing a rat model of HD (HD rat) and to extrapolate this result to the drug removal rate in HD patients. HD rats received bilateral nephrectomy and HD for 2 h. The dialysis removal of 6 drugs was evaluated in HD rats. Dialysis efficiency, plasma protein binding rate (PBR) and distribution volume (Vd) of drugs were also measured. Furthermore, we examined the correlation between the dialyzability of drug in HD rats and humans and constructed the prediction formula of the drug dialyzability in HD patients. The clearance of urea and creatinine and normalized dialysis dose in HD rats were 0.83 ± 0.07 mL/min, 0.70 ± 0.08 mL/min, and 0.13 ± 0.06, respectively. The drug dialyzability in HD rats was similar to reported clinical data except for doripenem. A higher correlation was observed between drug dialyzability in reported clinical data and HD rats which were adjusted for PBR (r.sup.2 = 0.936; p &lt; 0.001) compared to unadjusted (r.sup.2 = 0.812; p = 0.009). Therefore, we constructed the prediction formula of the drug dialyzability in HD patients by utilizing the HD rat model and PBR. This study is useful for evaluating the dialyzability of high-risk drugs in a clinical setting and might provide appropriate preclinical dialyzability data for new drug.</abstract><cop>San Francisco</cop><pub>Public Library of Science</pub><pmid>32530952</pmid><doi>10.1371/journal.pone.0233925</doi><tpages>e0233925</tpages><orcidid>https://orcid.org/0000-0003-3821-5966</orcidid><orcidid>https://orcid.org/0000-0003-1584-249X</orcidid><orcidid>https://orcid.org/0000-0002-3064-1963</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1932-6203
ispartof PloS one, 2020-06, Vol.15 (6), p.e0233925-e0233925
issn 1932-6203
1932-6203
language eng
recordid cdi_plos_journals_2412532996
source DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Free Full-Text Journals in Chemistry; Public Library of Science (PLoS)
subjects Analysis
Animals
Biology and Life Sciences
Catheters
Correlation
Correlation analysis
Creatinine
Dialysate
Dialysis
Dialyzers
Dosage
Drug development
Drug dosages
Drug interactions
Drug therapy
Drugs
Engineering and Technology
Evaluation
Hemodialysis
Hemodialysis patients
Laboratories
Medicine and Health Sciences
Nephrectomy
Pharmaceutical sciences
Pharmacy
Physical Sciences
Physiology
R&D
Research & development
Research and Analysis Methods
Sodium
Urea
Veins & arteries
title In vivo evaluation of drug dialyzability in a rat model of hemodialysis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T21%3A43%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=In%20vivo%20evaluation%20of%20drug%20dialyzability%20in%20a%20rat%20model%20of%20hemodialysis&rft.jtitle=PloS%20one&rft.au=Fukunaga,%20Masaki&rft.date=2020-06-12&rft.volume=15&rft.issue=6&rft.spage=e0233925&rft.epage=e0233925&rft.pages=e0233925-e0233925&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0233925&rft_dat=%3Cgale_plos_%3EA626469863%3C/gale_plos_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2412532996&rft_id=info:pmid/32530952&rft_galeid=A626469863&rft_doaj_id=oai_doaj_org_article_0411000611ae4ea4a8b5c0f1f817187d&rfr_iscdi=true